Clinical Trial Detail

NCT ID NCT03250299
Title Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

glioblastoma multiforme

Therapies

BAL101553

Age Groups: adult senior

No variant requirements are available.